Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
SSI Diagnostica A/S
A/S
Active
CVR 37294535
Herredsvejen 2, 3400
Hillerød
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2015 · 10 years old
156 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
SSI Diagnostica A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
398M
299M
199M
100M
0M
2021: 274M
274M
2021
2022: 316M (+15% vs 2021)
316M
+15%
2022
2023: 203M (-36% vs 2022)
203M
-36%
2023
2024: 238M (+17% vs 2023)
238M
+17%
2024
2025: 320M (+34% vs 2024)
320M
+34%
2025
EBITDA
DKK millions
289M
198M
106M
14M
-77M
2021: 217M
217M
2021
2022: -5M (-102% vs 2021)
-5M
-102%
2022
2023: 54M (+1180% vs 2022)
54M
+1180%
2023
2024: 38M (-30% vs 2023)
38M
-30%
2024
2025: 6M (-84% vs 2024)
6M
-84%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Revenue
320.248
238.338
202.776
316.074
274.461
Staff expenses
-104.478
-83.794
-53.849
-0
-57.502
EBITDA
5.943
37.659
53.532
-4.952
216.819
Depreciation & amort.
-47.588
-17.267
-28.650
-0
-16.774
EBIT
-41.644
20.391
24.882
-4.952
200.045
Net financials
-77.156
-81.992
-132.998
31.413
90.618
Profit before tax
-118.800
-61.601
-108.116
26.461
290.804
Tax
-11.380
-3.863
8.229
-11.601
39.384
Net profit
-107.420
-57.738
-126.826
38.062
251.420
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
2.976.120
2.672.997
2.722.933
3.185.375
999.322
Equity
695.791
1.270.028
1.247.705
1.016.146
690.076
Long-term debt
2.108.959
1.234.813
1.314.228
1.397.841
103.468
Short-term debt
153.832
139.326
132.170
756.250
178.941
Total debt
2.262.792
1.374.139
1.446.399
2.154.091
282.409
Financial ratios
5-year trend
EBITDA margin
1,9 %
This company
15,8 %
Market median
This company
Market median
88% below market
2021
2025
Equity ratio
23,4 %
This company
38,2 %
Market median
This company
Market median
39% below market
2021
2025
Return on equity
-15,4 %
This company
18,4 %
Market median
This company
Market median
184% below market
2021
2025
Net profit margin
-33,5 %
This company
8,1 %
Market median
This company
Market median
514% below market
2021
2025
Asset turnover
0,11×
This company
1,12×
Market median
This company
Market median
90% below market
2021
2025
Debt / equity
3,28×
This company
0,62×
Market median
This company
Market median
429% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on SSI Diagnostica A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
